Pooling resources and sharing knowledge for improving the quality of medicines in developing countries. The experience of QUAMED.
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: RAVINETTO, Raffaella (Institute Tropical medicine, Public Health, Antwerp, Belgium)
- Co-author(s): Raffaella Ravinetto:|Corinne Pouget:QUAMED,Institute Tropical medicine,Antwerp,Belgium|Jean-Michel Caudron:QUAMED,Institute Tropical medicine,Antwerp,Belgium|Jean-Michel Cann:QUAMED,Institute Tropical medicine,Antwerp,Belgium|Vera Melotte:QUAMED,Institute Tropical medicine,Antwerp,Belgium|Bruno Meessen:Public Health,Institute Tropical medicine,Antwerp,Belgium|Roberta Barros Coelho Neto:QUAMED,Institute Tropical Medicine,Antwerp,Belgium
The Sustainable Development Goal 3.8 aims at universal health coverage, including quality and affordable essential medicines and vaccines for all. But the increasing globalization of pharmaceutical production makes it difficult to assess quality of medicines, especially in low and middle income countries (LMICs), where under-resourced regulatory.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.